The global market for Mental Disorders Drugs was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Mental Disorders Drugs, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Mental Disorders Drugs by region & country, by Type, and by Application.

The Mental Disorders Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Mental Disorders Drugs.

Market Segmentation

Scope of Mental Disorders Drugs - Market Report

Report Metric	Details
Report Name	Mental Disorders Drugs - Market
CAGR	5%
Segment by Type:	Drugs for Schizophrenia Antidepressants Antipsychotics Anxiolytics Drugs for the Treatment of Substance and Alcohol Addiction Drugs for Childhood and Adolescent Mental Illness Drugs to Treat Cognitive Disorders Sleep Disorders Others
Segment by Application	Children Adolescents Adults
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Johnson & Johnson, Pfizer, Eli Lilly, GlaxoSmithKline, AstraZeneca, Bristol-Myers Squibb, Abbott Laboratories
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Mental Disorders Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Mental Disorders Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Mental Disorders Drugs in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

FAQ for this report

Who are the main players in the Mental Disorders Drugs - Market report?

Ans: The main players in the Mental Disorders Drugs - Market are Johnson & Johnson, Pfizer, Eli Lilly, GlaxoSmithKline, AstraZeneca, Bristol-Myers Squibb, Abbott Laboratories

What are the Application segmentation covered in the Mental Disorders Drugs - Market report?

Ans: The Applications covered in the Mental Disorders Drugs - Market report are Children, Adolescents, Adults

What are the Type segmentation covered in the Mental Disorders Drugs - Market report?

Ans: The Types covered in the Mental Disorders Drugs - Market report are Drugs for Schizophrenia, Antidepressants, Antipsychotics, Anxiolytics, Drugs for the Treatment of Substance and Alcohol Addiction, Drugs for Childhood and Adolescent Mental Illness, Drugs to Treat Cognitive Disorders, Sleep Disorders, Others

1 Market Overview

1.1 Mental Disorders Drugs Product Introduction

1.2 Global Mental Disorders Drugs Market Size Forecast

1.2.1 Global Mental Disorders Drugs Sales Value (2019-2030)

1.2.2 Global Mental Disorders Drugs Sales Volume (2019-2030)

1.2.3 Global Mental Disorders Drugs Sales Price (2019-2030)

1.3 Mental Disorders Drugs Market Trends & Drivers

1.3.1 Mental Disorders Drugs Industry Trends

1.3.2 Mental Disorders Drugs Market Drivers & Opportunity

1.3.3 Mental Disorders Drugs Market Challenges

1.3.4 Mental Disorders Drugs Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Mental Disorders Drugs Players Revenue Ranking (2023)

2.2 Global Mental Disorders Drugs Revenue by Company (2019-2024)

2.3 Global Mental Disorders Drugs Players Sales Volume Ranking (2023)

2.4 Global Mental Disorders Drugs Sales Volume by Company Players (2019-2024)

2.5 Global Mental Disorders Drugs Average Price by Company (2019-2024)

2.6 Key Manufacturers Mental Disorders Drugs Manufacturing Base Distribution and Headquarters

2.7 Key Manufacturers Mental Disorders Drugs Product Offered

2.8 Key Manufacturers Time to Begin Mass Production of Mental Disorders Drugs

2.9 Mental Disorders Drugs Market Competitive Analysis

2.9.1 Mental Disorders Drugs Market Concentration Rate (2019-2024)

2.9.2 Global 5 and 10 Largest Manufacturers by Mental Disorders Drugs Revenue in 2023

2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Mental Disorders Drugs as of 2023)

2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Drugs for Schizophrenia

3.1.2 Antidepressants

3.1.3 Antipsychotics

3.1.4 Anxiolytics

3.1.5 Drugs for the Treatment of Substance and Alcohol Addiction

3.1.6 Drugs for Childhood and Adolescent Mental Illness

3.1.7 Drugs to Treat Cognitive Disorders

3.1.8 Sleep Disorders

3.1.9 Others

3.2 Global Mental Disorders Drugs Sales Value by Type

3.2.1 Global Mental Disorders Drugs Sales Value by Type (2019 VS 2023 VS 2030)

3.2.2 Global Mental Disorders Drugs Sales Value, by Type (2019-2030)

3.2.3 Global Mental Disorders Drugs Sales Value, by Type (%) (2019-2030)

3.3 Global Mental Disorders Drugs Sales Volume by Type

3.3.1 Global Mental Disorders Drugs Sales Volume by Type (2019 VS 2023 VS 2030)

3.3.2 Global Mental Disorders Drugs Sales Volume, by Type (2019-2030)

3.3.3 Global Mental Disorders Drugs Sales Volume, by Type (%) (2019-2030)

3.4 Global Mental Disorders Drugs Average Price by Type (2019-2030)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Children

4.1.2 Adolescents

4.1.3 Adults

4.2 Global Mental Disorders Drugs Sales Value by Application

4.2.1 Global Mental Disorders Drugs Sales Value by Application (2019 VS 2023 VS 2030)

4.2.2 Global Mental Disorders Drugs Sales Value, by Application (2019-2030)

4.2.3 Global Mental Disorders Drugs Sales Value, by Application (%) (2019-2030)

4.3 Global Mental Disorders Drugs Sales Volume by Application

4.3.1 Global Mental Disorders Drugs Sales Volume by Application (2019 VS 2023 VS 2030)

4.3.2 Global Mental Disorders Drugs Sales Volume, by Application (2019-2030)

4.3.3 Global Mental Disorders Drugs Sales Volume, by Application (%) (2019-2030)

4.4 Global Mental Disorders Drugs Average Price by Application (2019-2030)

5 Segmentation by Region

5.1 Global Mental Disorders Drugs Sales Value by Region

5.1.1 Global Mental Disorders Drugs Sales Value by Region: 2019 VS 2023 VS 2030

5.1.2 Global Mental Disorders Drugs Sales Value by Region (2019-2024)

5.1.3 Global Mental Disorders Drugs Sales Value by Region (2025-2030)

5.1.4 Global Mental Disorders Drugs Sales Value by Region (%), (2019-2030)

5.2 Global Mental Disorders Drugs Sales Volume by Region

5.2.1 Global Mental Disorders Drugs Sales Volume by Region: 2019 VS 2023 VS 2030

5.2.2 Global Mental Disorders Drugs Sales Volume by Region (2019-2024)

5.2.3 Global Mental Disorders Drugs Sales Volume by Region (2025-2030)

5.2.4 Global Mental Disorders Drugs Sales Volume by Region (%), (2019-2030)

5.3 Global Mental Disorders Drugs Average Price by Region (2019-2030)

5.4 North America

5.4.1 North America Mental Disorders Drugs Sales Value, 2019-2030

5.4.2 North America Mental Disorders Drugs Sales Value by Country (%), 2023 VS 2030

5.5 Europe

5.5.1 Europe Mental Disorders Drugs Sales Value, 2019-2030

5.5.2 Europe Mental Disorders Drugs Sales Value by Country (%), 2023 VS 2030

5.6 Asia Pacific

5.6.1 Asia Pacific Mental Disorders Drugs Sales Value, 2019-2030

5.6.2 Asia Pacific Mental Disorders Drugs Sales Value by Country (%), 2023 VS 2030

5.7 South America

5.7.1 South America Mental Disorders Drugs Sales Value, 2019-2030

5.7.2 South America Mental Disorders Drugs Sales Value by Country (%), 2023 VS 2030

5.8 Middle East & Africa

5.8.1 Middle East & Africa Mental Disorders Drugs Sales Value, 2019-2030

5.8.2 Middle East & Africa Mental Disorders Drugs Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Mental Disorders Drugs Sales Value Growth Trends, 2019 VS 2023 VS 2030

6.2 Key Countries/Regions Mental Disorders Drugs Sales Value

6.2.1 Key Countries/Regions Mental Disorders Drugs Sales Value, 2019-2030

6.2.2 Key Countries/Regions Mental Disorders Drugs Sales Volume, 2019-2030

6.3 United States

6.3.1 United States Mental Disorders Drugs Sales Value, 2019-2030

6.3.2 United States Mental Disorders Drugs Sales Value by Type (%), 2023 VS 2030

6.3.3 United States Mental Disorders Drugs Sales Value by Application, 2023 VS 2030

6.4 Europe

6.4.1 Europe Mental Disorders Drugs Sales Value, 2019-2030

6.4.2 Europe Mental Disorders Drugs Sales Value by Type (%), 2023 VS 2030

6.4.3 Europe Mental Disorders Drugs Sales Value by Application, 2023 VS 2030

6.5 China

6.5.1 China Mental Disorders Drugs Sales Value, 2019-2030

6.5.2 China Mental Disorders Drugs Sales Value by Type (%), 2023 VS 2030

6.5.3 China Mental Disorders Drugs Sales Value by Application, 2023 VS 2030

6.6 Japan

6.6.1 Japan Mental Disorders Drugs Sales Value, 2019-2030

6.6.2 Japan Mental Disorders Drugs Sales Value by Type (%), 2023 VS 2030

6.6.3 Japan Mental Disorders Drugs Sales Value by Application, 2023 VS 2030

6.7 South Korea

6.7.1 South Korea Mental Disorders Drugs Sales Value, 2019-2030

6.7.2 South Korea Mental Disorders Drugs Sales Value by Type (%), 2023 VS 2030

6.7.3 South Korea Mental Disorders Drugs Sales Value by Application, 2023 VS 2030

6.8 Southeast Asia

6.8.1 Southeast Asia Mental Disorders Drugs Sales Value, 2019-2030

6.8.2 Southeast Asia Mental Disorders Drugs Sales Value by Type (%), 2023 VS 2030

6.8.3 Southeast Asia Mental Disorders Drugs Sales Value by Application, 2023 VS 2030

6.9 India

6.9.1 India Mental Disorders Drugs Sales Value, 2019-2030

6.9.2 India Mental Disorders Drugs Sales Value by Type (%), 2023 VS 2030

6.9.3 India Mental Disorders Drugs Sales Value by Application, 2023 VS 2030

7 Company Profiles

7.1 Johnson & Johnson

7.1.1 Johnson & Johnson Company Information

7.1.2 Johnson & Johnson Introduction and Business Overview

7.1.3 Johnson & Johnson Mental Disorders Drugs Sales, Revenue and Gross Margin (2019-2024)

7.1.4 Johnson & Johnson Mental Disorders Drugs Product Offerings

7.1.5 Johnson & Johnson Recent Development

7.2 Pfizer

7.2.1 Pfizer Company Information

7.2.2 Pfizer Introduction and Business Overview

7.2.3 Pfizer Mental Disorders Drugs Sales, Revenue and Gross Margin (2019-2024)

7.2.4 Pfizer Mental Disorders Drugs Product Offerings

7.2.5 Pfizer Recent Development

7.3 Eli Lilly

7.3.1 Eli Lilly Company Information

7.3.2 Eli Lilly Introduction and Business Overview

7.3.3 Eli Lilly Mental Disorders Drugs Sales, Revenue and Gross Margin (2019-2024)

7.3.4 Eli Lilly Mental Disorders Drugs Product Offerings

7.3.5 Eli Lilly Recent Development

7.4 GlaxoSmithKline

7.4.1 GlaxoSmithKline Company Information

7.4.2 GlaxoSmithKline Introduction and Business Overview

7.4.3 GlaxoSmithKline Mental Disorders Drugs Sales, Revenue and Gross Margin (2019-2024)

7.4.4 GlaxoSmithKline Mental Disorders Drugs Product Offerings

7.4.5 GlaxoSmithKline Recent Development

7.5 AstraZeneca

7.5.1 AstraZeneca Company Information

7.5.2 AstraZeneca Introduction and Business Overview

7.5.3 AstraZeneca Mental Disorders Drugs Sales, Revenue and Gross Margin (2019-2024)

7.5.4 AstraZeneca Mental Disorders Drugs Product Offerings

7.5.5 AstraZeneca Recent Development

7.6 Bristol-Myers Squibb

7.6.1 Bristol-Myers Squibb Company Information

7.6.2 Bristol-Myers Squibb Introduction and Business Overview

7.6.3 Bristol-Myers Squibb Mental Disorders Drugs Sales, Revenue and Gross Margin (2019-2024)

7.6.4 Bristol-Myers Squibb Mental Disorders Drugs Product Offerings

7.6.5 Bristol-Myers Squibb Recent Development

7.7 Abbott Laboratories

7.7.1 Abbott Laboratories Company Information

7.7.2 Abbott Laboratories Introduction and Business Overview

7.7.3 Abbott Laboratories Mental Disorders Drugs Sales, Revenue and Gross Margin (2019-2024)

7.7.4 Abbott Laboratories Mental Disorders Drugs Product Offerings

7.7.5 Abbott Laboratories Recent Development

8 Industry Chain Analysis

8.1 Mental Disorders Drugs Industrial Chain

8.2 Mental Disorders Drugs Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Mental Disorders Drugs Sales Model

8.5.2 Sales Channel

8.5.3 Mental Disorders Drugs Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.2 Data Source

10.2 Author Details

10.3 Disclaimer

FEATURED COMPANIES

List of Tables

Table 1. Mental Disorders Drugs Market Trends

Table 2. Mental Disorders Drugs Market Drivers & Opportunity

Table 3. Mental Disorders Drugs Market Challenges

Table 4. Mental Disorders Drugs Market Restraints

Table 5. Global Mental Disorders Drugs Revenue by Company (2019-2024) & (US$ Million)

Table 6. Global Mental Disorders Drugs Revenue Market Share by Company (2019-2024)

Table 7. Global Mental Disorders Drugs Sales Volume by Company (2019-2024) & (K Units)

Table 8. Global Mental Disorders Drugs Sales Volume Market Share by Company (2019-2024)

Table 9. Global Market Mental Disorders Drugs Price by Company (2019-2024) & (USD/Pcs)

Table 10. Key Manufacturers Mental Disorders Drugs Manufacturing Base Distribution and Headquarters

Table 11. Key Manufacturers Mental Disorders Drugs Product Type

Table 12. Key Manufacturers Time to Begin Mass Production of Mental Disorders Drugs

Table 13. Global Mental Disorders Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Mental Disorders Drugs as of 2023)

Table 15. Mergers & Acquisitions, Expansion Plans

Table 16. Global Mental Disorders Drugs Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 17. Global Mental Disorders Drugs Sales Value by Type (2019-2024) & (US$ Million)

Table 18. Global Mental Disorders Drugs Sales Value by Type (2025-2030) & (US$ Million)

Table 19. Global Mental Disorders Drugs Sales Market Share in Value by Type (2019-2024) & (%)

Table 20. Global Mental Disorders Drugs Sales Market Share in Value by Type (2025-2030) & (%)

Table 21. Global Mental Disorders Drugs Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)

Table 22. Global Mental Disorders Drugs Sales Volume by Type (2019-2024) & (K Units)

Table 23. Global Mental Disorders Drugs Sales Volume by Type (2025-2030) & (K Units)

Table 24. Global Mental Disorders Drugs Sales Market Share in Volume by Type (2019-2024) & (%)

Table 25. Global Mental Disorders Drugs Sales Market Share in Volume by Type (2025-2030) & (%)

Table 26. Global Mental Disorders Drugs Price by Type (2019-2024) & (USD/Pcs)

Table 27. Global Mental Disorders Drugs Price by Type (2025-2030) & (USD/Pcs)

Table 28. Global Mental Disorders Drugs Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 29. Global Mental Disorders Drugs Sales Value by Application (2019-2024) & (US$ Million)

Table 30. Global Mental Disorders Drugs Sales Value by Application (2025-2030) & (US$ Million)

Table 31. Global Mental Disorders Drugs Sales Market Share in Value by Application (2019-2024) & (%)

Table 32. Global Mental Disorders Drugs Sales Market Share in Value by Application (2025-2030) & (%)

Table 33. Global Mental Disorders Drugs Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)

Table 34. Global Mental Disorders Drugs Sales Volume by Application (2019-2024) & (K Units)

Table 35. Global Mental Disorders Drugs Sales Volume by Application (2025-2030) & (K Units)

Table 36. Global Mental Disorders Drugs Sales Market Share in Volume by Application (2019-2024) & (%)

Table 37. Global Mental Disorders Drugs Sales Market Share in Volume by Application (2025-2030) & (%)

Table 38. Global Mental Disorders Drugs Price by Application (2019-2024) & (USD/Pcs)

Table 39. Global Mental Disorders Drugs Price by Application (2025-2030) & (USD/Pcs)

Table 40. Global Mental Disorders Drugs Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Global Mental Disorders Drugs Sales Value by Region (2019-2024) & (US$ Million)

Table 42. Global Mental Disorders Drugs Sales Value by Region (2025-2030) & (US$ Million)

Table 43. Global Mental Disorders Drugs Sales Value by Region (2019-2024) & (%)

Table 44. Global Mental Disorders Drugs Sales Value by Region (2025-2030) & (%)

Table 45. Global Mental Disorders Drugs Sales Volume by Region (K Units): 2019 VS 2023 VS 2030

Table 46. Global Mental Disorders Drugs Sales Volume by Region (2019-2024) & (K Units)

Table 47. Global Mental Disorders Drugs Sales Volume by Region (2025-2030) & (K Units)

Table 48. Global Mental Disorders Drugs Sales Volume by Region (2019-2024) & (%)

Table 49. Global Mental Disorders Drugs Sales Volume by Region (2025-2030) & (%)

Table 50. Global Mental Disorders Drugs Average Price by Region (2019-2024) & (USD/Pcs)

Table 51. Global Mental Disorders Drugs Average Price by Region (2025-2030) & (USD/Pcs)

Table 52. Key Countries/Regions Mental Disorders Drugs Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030

Table 53. Key Countries/Regions Mental Disorders Drugs Sales Value, (2019-2024) & (US$ Million)

Table 54. Key Countries/Regions Mental Disorders Drugs Sales Value, (2025-2030) & (US$ Million)

Table 55. Key Countries/Regions Mental Disorders Drugs Sales Volume, (2019-2024) & (K Units)

Table 56. Key Countries/Regions Mental Disorders Drugs Sales Volume, (2025-2030) & (K Units)

Table 57. Johnson & Johnson Company Information

Table 58. Johnson & Johnson Introduction and Business Overview

Table 59. Johnson & Johnson Mental Disorders Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)

Table 60. Johnson & Johnson Mental Disorders Drugs Product Offerings

Table 61. Johnson & Johnson Recent Development

Table 62. Pfizer Company Information

Table 63. Pfizer Introduction and Business Overview

Table 64. Pfizer Mental Disorders Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)

Table 65. Pfizer Mental Disorders Drugs Product Offerings

Table 66. Pfizer Recent Development

Table 67. Eli Lilly Company Information

Table 68. Eli Lilly Introduction and Business Overview

Table 69. Eli Lilly Mental Disorders Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)

Table 70. Eli Lilly Mental Disorders Drugs Product Offerings

Table 71. Eli Lilly Recent Development

Table 72. GlaxoSmithKline Company Information

Table 73. GlaxoSmithKline Introduction and Business Overview

Table 74. GlaxoSmithKline Mental Disorders Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)

Table 75. GlaxoSmithKline Mental Disorders Drugs Product Offerings

Table 76. GlaxoSmithKline Recent Development

Table 77. AstraZeneca Company Information

Table 78. AstraZeneca Introduction and Business Overview

Table 79. AstraZeneca Mental Disorders Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)

Table 80. AstraZeneca Mental Disorders Drugs Product Offerings

Table 81. AstraZeneca Recent Development

Table 82. Bristol-Myers Squibb Company Information

Table 83. Bristol-Myers Squibb Introduction and Business Overview

Table 84. Bristol-Myers Squibb Mental Disorders Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)

Table 85. Bristol-Myers Squibb Mental Disorders Drugs Product Offerings

Table 86. Bristol-Myers Squibb Recent Development

Table 87. Abbott Laboratories Company Information

Table 88. Abbott Laboratories Introduction and Business Overview

Table 89. Abbott Laboratories Mental Disorders Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)

Table 90. Abbott Laboratories Mental Disorders Drugs Product Offerings

Table 91. Abbott Laboratories Recent Development

Table 92. Key Raw Materials Lists

Table 93. Raw Materials Key Suppliers Lists

Table 94. Mental Disorders Drugs Downstream Customers

Table 95. Mental Disorders Drugs Distributors List

Table 96. Research Programs/Design for This Report

Table 97. Key Data Information from Secondary Sources

Table 98. Key Data Information from Primary Sources

List of Figures

Figure 1. Mental Disorders Drugs Product Picture

Figure 2. Global Mental Disorders Drugs Sales Value, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Mental Disorders Drugs Sales Value (2019-2030) & (US$ Million)

Figure 4. Global Mental Disorders Drugs Sales Volume (2019-2030) & (K Units)

Figure 5. Global Mental Disorders Drugs Sales Price (2019-2030) & (USD/Pcs)

Figure 6. Mental Disorders Drugs Report Years Considered

Figure 7. Global Mental Disorders Drugs Players Revenue Ranking (2023) & (US$ Million)

Figure 8. Global Mental Disorders Drugs Players Sales Volume Ranking (2023) & (K Units)

Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Mental Disorders Drugs Revenue in 2023

Figure 10. Mental Disorders Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 11. Drugs for Schizophrenia Picture

Figure 12. Antidepressants Picture

Figure 13. Antipsychotics Picture

Figure 14. Anxiolytics Picture

Figure 15. Drugs for the Treatment of Substance and Alcohol Addiction Picture

Figure 16. Drugs for Childhood and Adolescent Mental Illness Picture

Figure 17. Drugs to Treat Cognitive Disorders Picture

Figure 18. Sleep Disorders Picture

Figure 19. Others Picture

Figure 20. Global Mental Disorders Drugs Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)

Figure 21. Global Mental Disorders Drugs Sales Value Market Share by Type, 2023 & 2030

Figure 22. Global Mental Disorders Drugs Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)

Figure 23. Global Mental Disorders Drugs Sales Volume Market Share by Type, 2023 & 2030

Figure 24. Global Mental Disorders Drugs Price by Type (2019-2030) & (USD/Pcs)

Figure 25. Product Picture of Children

Figure 26. Product Picture of Adolescents

Figure 27. Product Picture of Adults

Figure 28. Global Mental Disorders Drugs Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)

Figure 29. Global Mental Disorders Drugs Sales Value Market Share by Application, 2023 & 2030

Figure 30. Global Mental Disorders Drugs Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)

Figure 31. Global Mental Disorders Drugs Sales Volume Market Share by Application, 2023 & 2030

Figure 32. Global Mental Disorders Drugs Price by Application (2019-2030) & (USD/Pcs)

Figure 33. North America Mental Disorders Drugs Sales Value (2019-2030) & (US$ Million)

Figure 34. North America Mental Disorders Drugs Sales Value by Country (%), 2023 VS 2030

Figure 35. Europe Mental Disorders Drugs Sales Value (2019-2030) & (US$ Million)

Figure 36. Europe Mental Disorders Drugs Sales Value by Country (%), 2023 VS 2030

Figure 37. Asia Pacific Mental Disorders Drugs Sales Value (2019-2030) & (US$ Million)

Figure 38. Asia Pacific Mental Disorders Drugs Sales Value by Country (%), 2023 VS 2030

Figure 39. South America Mental Disorders Drugs Sales Value (2019-2030) & (US$ Million)

Figure 40. South America Mental Disorders Drugs Sales Value by Country (%), 2023 VS 2030

Figure 41. Middle East & Africa Mental Disorders Drugs Sales Value (2019-2030) & (US$ Million)

Figure 42. Middle East & Africa Mental Disorders Drugs Sales Value by Country (%), 2023 VS 2030

Figure 43. Key Countries/Regions Mental Disorders Drugs Sales Value (%), (2019-2030)

Figure 44. Key Countries/Regions Mental Disorders Drugs Sales Volume (%), (2019-2030)

Figure 45. United States Mental Disorders Drugs Sales Value, (2019-2030) & (US$ Million)

Figure 46. United States Mental Disorders Drugs Sales Value by Type (%), 2023 VS 2030

Figure 47. United States Mental Disorders Drugs Sales Value by Application (%), 2023 VS 2030

Figure 48. Europe Mental Disorders Drugs Sales Value, (2019-2030) & (US$ Million)

Figure 49. Europe Mental Disorders Drugs Sales Value by Type (%), 2023 VS 2030

Figure 50. Europe Mental Disorders Drugs Sales Value by Application (%), 2023 VS 2030

Figure 51. China Mental Disorders Drugs Sales Value, (2019-2030) & (US$ Million)

Figure 52. China Mental Disorders Drugs Sales Value by Type (%), 2023 VS 2030

Figure 53. China Mental Disorders Drugs Sales Value by Application (%), 2023 VS 2030

Figure 54. Japan Mental Disorders Drugs Sales Value, (2019-2030) & (US$ Million)

Figure 55. Japan Mental Disorders Drugs Sales Value by Type (%), 2023 VS 2030

Figure 56. Japan Mental Disorders Drugs Sales Value by Application (%), 2023 VS 2030

Figure 57. South Korea Mental Disorders Drugs Sales Value, (2019-2030) & (US$ Million)

Figure 58. South Korea Mental Disorders Drugs Sales Value by Type (%), 2023 VS 2030

Figure 59. South Korea Mental Disorders Drugs Sales Value by Application (%), 2023 VS 2030

Figure 60. Southeast Asia Mental Disorders Drugs Sales Value, (2019-2030) & (US$ Million)

Figure 61. Southeast Asia Mental Disorders Drugs Sales Value by Type (%), 2023 VS 2030

Figure 62. Southeast Asia Mental Disorders Drugs Sales Value by Application (%), 2023 VS 2030

Figure 63. India Mental Disorders Drugs Sales Value, (2019-2030) & (US$ Million)

Figure 64. India Mental Disorders Drugs Sales Value by Type (%), 2023 VS 2030

Figure 65. India Mental Disorders Drugs Sales Value by Application (%), 2023 VS 2030

Figure 66. Mental Disorders Drugs Industrial Chain

Figure 67. Mental Disorders Drugs Manufacturing Cost Structure

Figure 68. Channels of Distribution (Direct Sales, and Distribution)

Figure 69. Bottom-up and Top-down Approaches for This Report

Figure 70. Data Triangulation

Figure 71. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3950

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Treatment for Mental Health Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Anxiety Disorders And Depression Therapeutic Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Depression MDD Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Depression Medicine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Major Depressive Disorder Drug Market Research Report 2025

Antidepressants Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Anxiety and Depression Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Antipsychotic Drug Market Research Report 2024

Clinical Disorder Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Psychiatric API Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Drug Free Depression Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global General Anxiety Disorder Therapeutics Market Research Report 2025

Global Antidepressant Medication Market Research Report 2025

Respiratory Disorders Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Neurologic Disorder Treatment Drug Market Research Report 2024

Prescription Medicine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Respiratory Disorders Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Behavioural Health Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Central Nervous System Disease Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

120 Pages

Type: Report

Code: QYRE-Auto-0V16594

Tue Jun 03 00:00:00 UTC 2025

Add to Cart

Global Selective Serotonin Reuptake Inhibitors (SSRIs) Drugs Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-36H16193

Tue Jun 03 00:00:00 UTC 2025

Add to Cart

Global Clomipramine Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-31E16108

Tue Jun 03 00:00:00 UTC 2025

Add to Cart

Global Clozapine Oral Suspension Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-17C15766

Fri May 30 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

Mental Disorders Drugs - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Published Date: September 2024

Report Code: QYRE-Auto-12T6869

Mental Disorders Drugs - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

FEATURED COMPANIES

Mental Disorders Drugs - Market Size

Mental Disorders Drugs - Market

Report Scope

Scope of Mental Disorders Drugs - Market Report

Chapter Outline

FAQ for this report

Who are the main players in the Mental Disorders Drugs - Market report?

What are the Application segmentation covered in the Mental Disorders Drugs - Market report?

What are the Type segmentation covered in the Mental Disorders Drugs - Market report?

FEATURED COMPANIES

RELATED REPORTS